Among women prescribed a semaglutide or tirzepatide medication, the percentage with a PCOS diagnosis increased from 4.6% in 2021 to 5.7% in 2025, a 23.9% relative increase. Nearly all PCOS patients prescribed semaglutide or tirzepatide also had obesity or type 2...
Respiratory virus–associated hospitalizations declined overall in October 2025 (–31.8%). The rate of RSV-associated hospitalizations in children under five more than doubled for the second consecutive month, signaling early seasonal activity. Rhinovirus remained the...
Respiratory virus–associated hospitalizations declined overall in September 2025 (–27.1%). COVID-associated hospitalizations declined substantially (-45.1%) but still account for the most virus-associated hospitalizations in those aged 65 and older (1.1%). Rhinovirus...
